Australians in dark on blood cancer symptoms, risking delayed diagnosis and potentially costing lives
- Media releases
Author: Michael Yare
Venetoclax received PBAC recommendation for AML
The 'miracle drug' was among eight blood cancer treatments recommended by the PBAC at its July 2021 meeting.
- Acute myeloid leukaemia
Expert Series: Dr Ilaria Pagani talks treatment-free remission in CML
Dr Pagani has a vision for a personalised approach to treatment-free remission in CML
- Chronic myeloid leukaemia
- Interviews with experts
- Research
Heather’s in treatment-free remission
Heather Jenkins was one of the first Australians to go on a clinical trial for the first targeted therapy for chronic myeloid leukaemia (CML).
- Chronic myeloid leukaemia
Revised AML, DLBCL and HL Optimal Care Pathways released
Newly revised optimal care pathways (OCPs) provide best practice information for the treatment and care of people living with acute myeloid leukaemia (AML), and diffuse large B-cell lymphoma (DLBCL) and Hodgkin lymphoma (HL).
- Acute myeloid leukaemia
- Chronic myeloid leukaemia
- Hodgkin lymphoma
Diane didn’t know leukaemia was a blood cancer – “I thought it’s what little kids get”
In this honest, humourous, and heartfelt first-person narrative, Diane Autio shares her experiences of being diagnosed with acute myeloid leukaemia (AML).
- Acute myeloid leukaemia
Expert Series: Dr Chun Fong on finding the keys to unlock AML
Dr Chun Fong believes that testing for minimal residual disease (MRD) is part of the answer.
- Acute myeloid leukaemia
- Interviews with experts
- Research
New trial aimed at keeping people with AML in remission
A new platform trial, a world first, could have transformative implications for people with resistant AML.
- Acute myeloid leukaemia
- Clinical trials
Aussies with blood cancer need more support than ever as COVID-19 and lockdowns prove detrimental to mental health, hinder access to care
- Media releases
- Research
Nick’s double blood cancer diagnosis and regaining hope
Diagnosed with two blood cancers, Nick's world changed instantly. Then transplant complications challenged him in ways he didn't expect.
- Acute lymphoblastic leukaemia
- Chronic myeloid leukaemia
- “Live life to the fullest”: Josh Gourlay opens up about returning to work and new beginnings after blood cancer
- Advocacy news – July 2024
- Talking Blood Cancer: Estate planning and medical directives
- Running for a Cause: Cal Gates’ Journey from Newcastle to Sydney on foot in one weekend
- World Blood Cancer Day 2024